All markets data located on FT.com is subject to the FT Terms & Conditions All content on FT.com is for your general information and use only and is not intended to address your particular ...
Swiss drugmaker Roche is reviewing all future investments in Germany over healthcare cost-cutting policies, the company's Germany chief said in an interview with newspaper Welt published on Monday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results